TABLE 1.
Target | Primer name | Primer sequence (5′–3′)a |
---|---|---|
HIV-1 integrants | Alu-F (1st cycle) | AGCCTCCCGAGTAGCTGGGA |
SB704 (1st cycle) | TGCTGGGATTACAGGCGTGAG | |
Gag-R (1st cycle) | CAATATCATACGCCGAGAGTGCGCGCTTCAGCAAG | |
LTR-F (2nd cycle) | TTGTTACACCCTATGAGCCAGC | |
Gag-R (2nd cycle) | CAATATCATACGCCGAGAGTGC | |
P-HUS-SS1 (probe) | FAM-TAGTGTGTGCCCGTCTGTTGTGTGAC-TAMRA | |
HIV-1 multiply spliced RNA | Tat-Rev-F | ATGGCAGGAAGAAGCGGAG |
Tat-Rev-R | ATTCCTTCGGGCCTGTCG | |
HIV-1 singly spliced RNA | Vpu-F | GGCGGCGACTGGAAGAAGC |
Vpu-R | CTATGATTACTATGGACCACAC | |
HIV-1 unspliced total RNA | Gag-F | GTGTGGAAAATCTCTAGCAGTGG |
Gag-R | CGCTCTCGCACCCATCTC | |
Late reverse transcription | MH531(F) | TGTGTGCCCGTCTGTTGTGT |
MH532(R) | GAGTCCTGCGTCGAGAGATC | |
LTR-P (probe) | FAM-CAGTGGCGCCCGAACAGGGA-TAMRA | |
β-Actin | Actin-F | GGGAAATCGTGCGTGACAT |
Actin-R | GTCAGGCAGCTCGTAGCTCTT |
FAM, 6-carboxyfluorescein; TAMRA, 6-carboxytetramethylrhodamine.